Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Collections

Filters ​

  • Collection |

    The rapid technological progress makes it possible to use DNA testing in settings outside of clinical genetics services. This implies that public health screening programmes are developing competences in genetics. The field of newborn screening has seen several pilots to offer testing of multiple genes to apparently healthy newborns, and regular newborn screening programs incorporate DNA testing for a handful of conditions, though often as second tier after biochemical testing. Breast cancer screening programmes consider incorporating DNA testing to stratify the programs and thus make them more personalized (WISDOM trial, MyPebs, etc). While research projects are ongoing, many policy makers in the field of public health discuss whether and where DNA testing could be used in population screening programmes. The EJHG welcomes reviews, commentaries, and original research on the topic of DNA in screening to be submitted before the end of December 2025.

    Open for submissions

  • Collection |

    The European Journal of Human Genetics (EJHG) is inviting submissions for a Special Issue on Hereditary Cancer. This issue will explore key advancements in the field, with a particular focus on polygenic risk scores (PRS) in cancer risk stratification, the role of precision oncology in hereditary cancer, innovative sequencing approaches, functional variant classification, and strategies for improving early detection and genetic testing accessibility. In addition to several commissioned articles, we welcome original research, reviews/perspectives that provide new insights into hereditary cancer, polygenic risk, and precision oncology in hereditary cancer. By bringing together diverse contributions, this Special Issue aims to highlight the latest scientific and clinical developments that may help understand the future of hereditary cancer care.

  • Collection |

    This special issue will bring together key work in this area, including outputs from a recent Brocher Foundation workshop ‘Severity in the genomic age: clarification and applications’ (June 2023).

  • Collection |

    The Editor of European Journal of Human Genetics is delighted to share with you an Editor's Choice selection of key papers that highlight some of the best current research published in the journal.

  • Collection |

    A special issue in EJHG on genomic testing in low and middle income countries. This is an important and timely topic, as genomic testing has the potential to revolutionize healthcare in these regions, but it also presents unique challenges and ethical considerations.

  • Collection |

    This collection covers articles on COVID-19 host genomics with an aim to increase our understanding of host genomic aspects that predispose to infection and transmission of COVID-19 and contribute to illness severity.

  • Collection |

    In this collection we highlight a selection of articles from 2021, which top the list of the journal’s most cited, downloaded and most shared (including press coverage, blogs, Twitter, Facebook and Weibo). They showcase the breadth of scope and coverage that the journal consistently delivers to its readers.

Search

Advanced search

Quick links